# Trio Impact Invest

> Trio Impact Invest is a VC fund backing Biotechnology and Biopharma. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jul 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/trioimpactinvest
- Website: https://www.trioimpactinvest.se

Trio Impact Invest is a venture capital investment firm.

## Contacts

5 contacts available for Trio Impact Invest. Shizune tracks 1 team members at Trio Impact Invest. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/trio-impact-invest?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Biopharma | 1 | 33% |
| CleanTech | 1 | 33% |
| Clean Energy | 1 | 33% |
| Pharmaceutical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Pre-Seed | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Siimon Vaske | Fund Manager and Chief Executive Officer | 3 | https://shizune.co/investors/profile/siimon-vaske-4187 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Caplyzer | Caplyzer develops and patented a new solution for water electrolysis. | $726.6K | Seed | Jul 07, 2026 |  |
| GenomeVault | GenomeVault is a biodiversity startup that converts eDNA from nature into scalable biodiversity insights using advanced genomics. | $515.3K | Pre-Seed | Jul 07, 2026 |  |
| AAX Biotech | AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. |  | Venture - Series Unknown | Feb 19, 2026 |  |

3 of 3 investments shown.

## Co-investors
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund, 1 deal together
- [Karolinska Institutet Innovation](https://shizune.co/investors/profile/karolinska-institutet-innovation) — VC Fund, 1 deal together
- [KTH Ventures](https://shizune.co/investors/profile/kth-ventures) — VC Fund, 1 deal together
- [Singularity University Ventures](https://shizune.co/investors/profile/singularity-university-ventures) — VC Fund, 1 deal together
- [Uppsala universitet Invest AB](https://shizune.co/investors/profile/uppsala-universitet-invest-ab) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Clean Energy Investors in Sweden](https://shizune.co/investors/clean-energy-investors-sweden)

## FAQ

### What does Trio Impact Invest invest in?

Trio Impact Invest invests primarily in Biotechnology, Biopharma and CleanTech startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Trio Impact Invest?

Public channels for Trio Impact Invest include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Trio Impact Invest?

The team at Trio Impact Invest includes Siimon Vaske (Fund Manager and Chief Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co